Posted in | News | Medical Robotics

New Report on Asia-Pacific Image-Guided Surgery and Robot-Assisted Surgery Market announces that a new market research report is available in its catalogue: Image-guided Surgery and Robot-assisted Surgery Market in Asia-Pacific

Developed Markets Experiment with the Latest Technologies in Surgery

This research service covers the revenues and trends in the Asia-Pacific (APAC) image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Higher disposable income, penetration of health insurance, and improvement in overall quality of life necessitate the need for quality healthcare services. This has led to investment in assistive technologies by private hospitals. There is also rising demand for efficient and patient-safety treatment protocols that could be achieved using IGS and RAS. With innovations in healthcare, there has been a significant transition from conventional and minimally invasive surgeries to use of assistive technologies such as IGS and RAS.


  • The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with manufacturers, distributors, and key opinion leaders for image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Most interviews were conducted with product managers and marketing managers.
  • The analysis contained in this research service is based on the following.
    • Information collected through discussions with market participants and from secondary sources—government, industry associations, companies, and other web sites and credible sources.
    • Public announcements and plans by OEMs, suppliers, new entrants, and distributors.
    • Frost & Sullivan's published research services and market and technology expertise.
  • Forecasts are guided by data and analysis based on the market dynamics. When specific market sizes were unavailable, estimates were extrapolated using a combination of secondary and primary research.
  • Industry-specific information obtained include:
    • Revenue breakdowns by technology segments and regions specific to the market
    • Company revenues, market share estimates, and projected growth rates
    • Market information, including customers, regional, and technology trends
    • Market drivers, restraints, and challenges

Key Findings

  • The total market for image-guided surgery (IGS) and robot-assisted surgery (RAS) in Asia-Pacific (APAC) was worth $Xmillion in 2013 and is expected to reach $X million in 2018, expanding at a CAGR of X%.
  • Japan accounted for about X% of the total market revenue in 2013, followed by Taiwan accounting for X%. Other APAC countries held X% share that year.
  • IGS has become well-accepted in most APAC countries. It is commonly used for neuro and spinal surgeries.
  • RAS has been gaining slow acceptance in most APAC countries. Regulatory environment and lower reimbursement are key deterrents to growth.
  • RAS for multi-functional surgeries account for more than X% of the total RAS revenue.
  • Adoption of IGS and RAS amongst healthcare providers varies considerably among the countries as well as among the public and private sectors. While Japan, Taiwan, South Korea, and Australia have high level of adoption of the technologies, most countries across the region are still in the early phase of adoption.
  • There continues to be significant confusion and apprehension regarding the safety of and the accuracy of the prognosis provided by RAS technologies.
  • Lack of surgeons specializing in IGS and RAS and constrained hospital budgets continue to dampen the adoption of assistive technologies in the region.

Scope and Segmentation

Geographic Segmentation: Asia-Pacific (APAC)
Study Period: 2011–2018
Base Year: 2013
Forecast Period: 2014–2018
Monetary Unit: US Dollars

Revenues for the total market are derived from two segments: IGS and RAS.
IGS: IGS in this study represents image guidance and navigation systems. Devices using sophisticated methodologies of image acquisition, computing, processing, and rendering to generate 3D reconstructions of the human anatomy.
RAS: RAS represents systems that use robotic technology to carry out prostate, stomach, cardiac, ortho, spine, and neurological procedures.
Price is defined as the average selling price of IGS and RAS systems.
Revenue is the income generated for the manufacturers from IGS and RAS systems sold to end users.
Asia-Pacific (APAC) includes Australia, South Korea, Japan, Taiwan, and SE Asia.
SE Asian countries inlude Singapore, Malaysia, Thailand, Indonesia, the Philippines, and Vietnam.

CEO's Perspective

  1. Proven benefits of IGS and RAS technologies are driving volume adoption in developed and developing APAC countries at a moderate rate.
  2. The views of surgeons and patients are vital in adoption of the technologies.
  3. Budget constraints along with lack of skilled workforce deter hefty investment in RAS by healthcare providers.
  4. IGS is an attractive alternative business model for medical imaging companies.
  5. Several robots, currently being developed for various applications, will enter the market during the next five years.

Key Questions This Study Will Answer

  • What is the market size and potential for IGS and RAS surgeries? How long will it continue to grow, and at what rate?
  • Are the existing competitors structured correctly to meet customer needs? What is the role of domestic manufacturers of IGS and RAS systems, and how does it impact the market?
  • What is the greatest challenge faced by the IGS and RAS market and how can it be overcome?
  • Which are the major countries for the market, and what are the important trends for each application of IGS and RAS?
  • Are the products offered in IGS and RAS currently meeting customer needs, or is additional development needed?
  • Are manufacturers in the IGS and RAS market ready to work independently, or do they need partnerships to take their business to the next level?


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.